Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Medicinal Chemistry|March 25, 2014
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenonesChih-Yi Chang, Hsun-Yueh Chuang, Hsueh-Yun Lee, et al.
Chemical Science|April 29, 2017
The dual capture of AsV and AsIII by UiO-66 and analoguesCornelius O Audu, Huong Giang T Nguyen, Chih-Yi Chang, et al.
Theranostics|July 27, 2017
miR-196a Enhances Neuronal Morphology through Suppressing RANBP10 to Provide Neuroprotection in Huntington's DiseaseLu-Shiun Her, Su-Han Mao, Chih-Yi Chang, et al.
Journal of Medicinal Chemistry|January 6, 2018
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in VivoHsueh-Yun Lee, Kunal Nepali, Fang-I Huang, et al.
Molecules (Basel, Switzerland)|October 14, 2023
Methanol Extracts from Cirsium japonicum DC. var. australe Kitam. and Their Active Components Reduce Intracellular Oxidative Stress in Caenorhabditis elegansPei-Ling Yen, Ting-An Lin, Wei Lin Chuah, et al.
Free Radical Biology & Medicine|November 5, 2018
Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's diseaseIssa Olakunle Yusuf, Hsiu-Mei Chen, Pei-Hsun Cheng, et al.
Molecular Neurobiology|January 9, 2021
Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease ModelsIssa Olakunle Yusuf, Hsiu-Mei Chen, Pei-Hsun Cheng, et al.
Life Sciences|December 31, 2020
FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cellsIssa Olakunle Yusuf, Hsiu-Mei Chen, Pei-Hsun Cheng, et al.
Brain Pathology (Zurich, Switzerland)|September 3, 2014
The Differential Profiling of Ubiquitin-Proteasome and Autophagy Systems in Different Tissues before the Onset of Huntington's Disease ModelsLu-Shiun Her, Jian-Yu Lin, Mu-Hui Fu, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 6, 2026
Wild-type C9orf72 drives proteasomal dysfunction and mutant aggregates via a Stat1-Isg15 axis in Huntington's diseaseSiew Chin Chan, Chih-Wei Tung, Chih-Yi Chang, et al.
Pageof 3